Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Other Operating Expenses (2016 - 2025)

CorMedix's Other Operating Expenses history spans 11 years, with the latest figure at -$4.1 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 149.62% year-over-year to -$4.1 million; the TTM value through Dec 2025 reached $17.9 million, down 15.96%, while the annual FY2025 figure was -$6.5 million, 122.62% down from the prior year.
  • Other Operating Expenses for Q4 2025 was -$4.1 million at CorMedix, down from $11.2 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $11.2 million in Q3 2025 and bottomed at -$4.1 million in Q4 2025.
  • The 5-year median for Other Operating Expenses is $5.4 million (2024), against an average of $4.3 million.
  • The largest annual shift saw Other Operating Expenses skyrocketed 405842700.0% in 2023 before it tumbled 149.62% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at -$2.0 in 2021, then surged by 150.0% to $1.0 in 2022, then surged by 405842700.0% to $4.1 million in 2023, then soared by 103.63% to $8.3 million in 2024, then crashed by 149.62% to -$4.1 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Other Operating Expenses are -$4.1 million (Q4 2025), $11.2 million (Q3 2025), and $6.4 million (Q2 2025).